Financhill
Back

Genelux 10K Form

Sell
44

GNLX
Genelux

Last Price:
$3.31
Seasonality Move:
-16.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GNLX News And Ratings

See the #1 stock for the next 7 days that we like better than GNLX

GNLX Financial Statistics

Sales & Book Value

Annual Sales: $8K
Cash Flow: $-5.5M
Price / Cash Flow: 0
Annual Sales: $0.79
Price / Book: 4.21

Profitability

EPS (TTM): -0.88000
Net Income (TTM): $-29.5M
Gross Margin: --
Return on Equity: -154.33%
Return on Assets: -97.21%

Genelux Earnings Forecast

Key Genelux Financial Ratios

  • The Research & Development expenses have been 237,475.00% of Revenue.
  • The Net Earning history of GNLX is -373,362.50% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Genelux Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GNLX
Website: genelux.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.72
Quick Ratio: 2.51

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GNLX Technical Analysis vs Fundamental Analysis

Sell
44
Genelux (GNLX) is a Sell

Is Genelux a Buy or a Sell?

  • Genelux stock is rated a Sell
    The current Genelux [GNLX] share price is $3.33. The Score for GNLX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.